Stankovic Srdjan R. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Oct 18, 2022
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-10-15−2,969→ 0 total→ Common Stock (2,969 underlying) - Sale
Common Stock
2022-10-15$15.81/sh−1,326$20,964→ 56,831 total - Exercise/Conversion
Common Stock
2022-10-15+2,969→ 58,157 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The restricted stock units vest in four equal annual installments beginning 10/15/19.